Literature DB >> 7350801

Perianeurysmal retroperitoneal fibrosis. An unusual cause of renal failure.

R M Serra, J E Engle, R E Jones, A C Schoolwerth.   

Abstract

Retroperitoneal fibrosis causing ureteral obstruction in association with an abdominal aortic aneurysm has been reported infrequently. However, the clinical presentation of patients with this entity and the histopathologic findings at surgery are similar to those in patients with idiopathic retroperitoneal fibrosis. We describe a patient with perianeurysmal fibrosis and bilateral ureteral obstruction who presented with severe renal failure. The diagnosis of an abdominal aortic aneurysm with perianeurysmal fibrosis was made only at the time of surgery to repair bilateral ureteral obstruction. Previous case reports of perianeurysmal fibrosis are reviewed, and possible pathogenetic mechanisms are discussed. It is important to consider the presence of an occult abdominal aortic aneurysm in patients suspected of having retroperitoneal fibrosis because of the serious prognostic and therapeutic implications.

Entities:  

Mesh:

Year:  1980        PMID: 7350801     DOI: 10.1016/0002-9343(80)90187-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Radiographic and clinical findings in unusual abdominal aortic aneurysms.

Authors:  R Raabe; P F Lawrence; P R Luers; F J Miller
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

2.  Chronic coronary periarteritis in two patients with chronic periaortitis.

Authors:  M J Mitchinson; D G Wight; J Arno; B B Milstein
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

3.  Idiopathic retroperitoneal fibrosis.

Authors:  S Kurata; T Nakamura; K Nakayasu; N Kondo; K Ofuji; H Hongo
Journal:  Jpn J Surg       Date:  1987-01

Review 4.  Hyper-IgG4 disease: report and characterisation of a new disease.

Authors:  Guy H Neild; Manuel Rodriguez-Justo; Catherine Wall; John O Connolly
Journal:  BMC Med       Date:  2006-10-06       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.